DHR vs XOM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Exxon Mobil Corporation · Energy
$154.46
-37.3% upside to fair value
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
XOM trades at a lower forward P/E
(23.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
XOM |
| Current Price |
$174.04 |
$154.46 |
| Fair Value Estimate |
$197.01 |
$96.85 |
| Upside to Fair Value |
+13.2%
|
-37.3%
|
| Market Cap |
$123.2B |
$642.0B |
| Forward P/E |
33.4x
|
23.2x
|
| EV / EBITDA |
20.3x
|
10.3x
|
| Price / Sales |
5.0x
|
2.0x
|
| Price / FCF |
23.3x
|
27.2x
|
| Revenue Growth YoY |
+3.7%
|
-1.3%
|
| Gross Margin |
60.7%
|
21.7%
|
| Operating Margin |
21.0%
|
10.5%
|
| Return on Equity |
7.1%
|
11.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.68%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Exxon Mobil Corporation operates as a global integrated oil and gas company with significant operations in upstream, energy products, chemical products, and specialty products segments. The company benefits from a highly experienced management team with decades of internal tenure, led by CEO Darren Woods. Despite strong cash flow generation and operational scale, Exxon is currently overvalued, tr…
Accumulation Zones
| Metric |
DHR |
XOM |
| Zone Low |
$147.76 |
$72.64 |
| Zone High |
$167.46 |
$82.32 |
| In Buy Zone? |
No
|
No
|